Results 171 to 180 of about 63,139 (225)

4CPS-019 Differences in meropenem dose adjustment with calculation of glomerular filtration ratethrough different formulas [PDF]

Natalia Vicente López, Álvaro Corral Alaejos, S Fernández Cañabate, Jose Jímenez Casaus, JS Roldan Gonzalez, M Corrales Paz, I Gil Navarro, MD Alonso Castañé, ML Paredes Bernaldo Quiros, GUILLERMO GODA MONTIJANO, Cristina Valiño   +10 more
openalex   +1 more source

Antimicrobial Resistance Patterns and Cumulative Antibiogram of Clinically Significant Bacteria From a Tertiary Hospital in Indonesia. [PDF]

Int J Microbiol
Bur R, Putra MAR, Puspandari N, Bahri S, Yuliana E, Barus NRV, Sari AA, Fairuza TD.   +7 more
europepmc   +1 more source

Characterization of outer membrane vesicles from Acinetobacter haemolyticus and their role in the dissemination of carbapenem resistance. [PDF]

Med Microbiol Immunol
Martínez-Gorgonio E, Del Carmen Rocha-Gracia R, Castañeda-Lucio M, Arenas-Hernández MMP, Cevallos MA, Sáenz Y, Lozano-Zarain P.   +6 more
europepmc   +1 more source

Does Prolonged Infusion Allow Lower Daily Dose of Meropenem than Bolus Dosing?

, 2009
Éric Poulin, Glen Brown
openalex   +2 more sources

A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis. [PDF]

Clin Infect Dis
de Jager V, Mockeliunas L, You H, Simonsson USH, Collings T, Upton CM, Bezuidenhout JA, Gupte N, Dorman SE, Nuermberger E, Lamichhane G, Diacon AH, Dooley KE.   +12 more
europepmc   +1 more source

Comparison of Two Different Doses of Ampicillin-Sulbactam as Part of Combination Therapy in the Treatment of Multidrug Resistant <i>Acinetobacter baumannii</i> Ventilator Associated Pneumonia: A Randomized Clinical Trial. [PDF]

Infect Drug Resist
Niknami E, Alavi Darazam I, Mahboubi A, Shabani M, Salamzadeh J, Sahraei Z.   +5 more
europepmc   +1 more source

Meropenem-Responsive Pandoraea apista Pneumonia Despite High-Level In Vitro Resistance: A Rare Case in an Older Non-cystic Fibrosis Patient. [PDF]

Cureus
Abdelgalil M, Diyab A.
europepmc   +1 more source

Beyond <i>mecA</i>: a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA. [PDF]

Antimicrob Agents Chemother
Sassman M, Karolak M, Dallaire M, Schaffer CE, Gartner C, Vary C, Rosato RR, Rosato AE.   +7 more
europepmc   +1 more source

Meropenem, Ceftazidime, and Polymyxin B combination therapy: a novel approach to combat antimicrobial resistance in MDR, XDR and PDR Escherichia coli

Siddhi A. Darji, Avani Raulji, Axita Patel, Himanshu Pandya, Rupal Patel, Chirag Patel, Bhaskar Datta, Devjani Banerjee   +7 more
openalex   +1 more source